Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2012-10-12

FDA Approved: GALANTAMINE — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

The FDA approved a supplemental application for galantamine from Aurobindo Pharma Limited under an ANDA, authorizing changes to the approved product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Galantamine (galantamine)

Snippet

SUPPL AP for GALANTAMINE (GALANTAMINE)